Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06769594 · ClinicalTrials.gov registry record
Next Generation CT System
A clinical trial of Computed Tomography, sponsored by GE Healthcare.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06769594: Recruiting study of Computed Tomography, sponsored by GE Healthcare.
NCT06769594 is a study of Computed Tomography that is actively recruiting participants, run by GE Healthcare. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06769594, a study of Computed Tomography, is actively recruiting participants, sponsored by GE Healthcare.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to collect data to evaluate utility of a next generation CT system in a clinical setting.
Primary Outcome
Number of investigational CT scans along with standard of care CT images
Conditions Studied
Interventions
- DEVICE Investigational CT Scan
Study Locations (1)
Wisconsin
- University of Wisconsin, Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2025-12 |
What NCT06769594 shows while recruiting
NCT06769594 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Computed Tomography appearing as the primary indexed condition, and to 1 intervention - of which Investigational CT Scan is the first listed.
NCT06769594 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06769594 about?
NCT06769594 is a clinical study titled "Next Generation CT System". The purpose of the study is to collect data to evaluate utility of a next generation CT system in a clinical setting.
What is the current status of trial NCT06769594?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-04-08. Estimated completion is 2025-12.
What conditions does trial NCT06769594 study?
This clinical trial studies the following conditions: Computed Tomography.
What interventions are being tested in trial NCT06769594?
The interventions under investigation include: Investigational CT Scan (DEVICE).
Who is sponsoring clinical trial NCT06769594?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06769594 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Computed Tomography
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI